Share Twitter Facebook LinkedIn Email Skyclarys, from Biogen, has become the first treatment for Friedreich’s ataxia (FA) to win regulatory approval in the European Union. Read More
With the U.S. election approaching, could American voters in Canada make a difference?October 3, 2024